Serum fatty acid binding protein-4 (FABP4) has been reported as higher in obese compared to lean breast cancer survivors [75] and is thought to play a role in breast cancer progression by facilitating provision of fatty acids to cancer cells [76]. This evidence concerns the gene FABP4 and breast cancer.